arrow
C

Chad Tang

the university of texas m d anderson cancer center
H指数:49
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Discordant molecular biomarkers in unfavorable intermediate-risk localized prostate cancer

不利的中危局限性前列腺癌中不一致的分子生物标志物

2026-08-250
OAAI
KIM-1 and Circulating Tumor DNA Are Prognostic Markers for Oligometastatic Clear-cell Renal Cell Carcinoma: Development of a Multivariable Prognostic Model

KIM-1和循环肿瘤DNA是寡转移透明细胞肾细胞癌的预后标志物: 多变量预后模型的发展

2026-02-280
PRE
Assessment of brachytherapy-induced prostate edema on postimplant dosimetric analysis in patients treated with magnetic resonance imaging-assisted radiosurgery (MARS)

评估MRI引导放射外科治疗(MARS)患者术中植入后剂量学分析中近距离放射治疗引起的前列腺水肿

2026-01-010
PRE
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers

高级泌尿肿瘤共识会议(AUC3)2025:肾细胞癌和尿路肿瘤管理的专家共识

2025-12-130
OAAI
Phase 2 trial of metastasis directed radiotherapy without systemic therapy (MRWS) for oligometastatic clear cell renal cell carcinoma (ccRCC) and investigation of circulating tumor DNA (ctDNA)

针对寡转移性透明细胞肾细胞癌(ccRCC)的靶向转移放疗(MRWS)且不联合系统治疗的Ⅱ期临床试验,并探究循环肿瘤DNA(ctDNA)

2025-10-010
OAAI
Metastasis-directed radiotherapy without systemic therapy for oligometastatic clear-cell renal-cell carcinoma: primary efficacy analysis of a single-arm, single-centre, phase 2 trial

寡转移性透明细胞肾细胞癌的转移灶定向放射治疗(无系统性治疗):一项单臂、单中心、II期试验的主要疗效分析

2025-09-040
PRE
Developing biomarkers and methods of risk stratification: Consensus statements from the International Kidney Cancer Symposium North America 2024 Think Tank

开发生物标志物和风险分层方法:国际肾癌研讨会北美2024年思辨研讨会的共识声明

2025-09-010
PRE
Continuous Androgen Deprivation Therapy with or Without Metastasis-directed Therapy for Oligometastatic Prostate Cancer: The Multicenter Phase 2 Randomized EXTEND Trial

持续性雄激素剥夺疗法联合或未联合转移灶定向治疗寡转移性前列腺癌:多中心II期随机EXTEND试验

2025-07-310
PRE
Adding Metastasis-Directed Therapy to Standard-of-Care Systemic Therapy for Oligometastatic Breast Cancer (EXTEND): A Multicenter, Randomized Phase 2 Trial
2025-03-010
PRE
Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma: A Case-Based Practice Guide
2025-01-012
PRE
Knowledge-based planning for fully automated radiation therapy treatment planning of 10 different cancer sites
2025-01-013
PRE